Preventive and curative effects of Calendula officinalis infusion in a dextran sulfate sodium (DSS)-induced colitis model in BALB/c mice
DOI:
https://doi.org/10.2298/ABS250418014BKeywords:
ulcerative colitis, Calendula officinalis, oxidative stress, dextran sodium sulfate (DSS)Abstract
Paper description:
- Calendula officinalis (Co) is known for its anti-inflammatory properties; its effects in the experimental model of dextran sulfate sodium (DSS)-induced colitis have not been thoroughly investigated.
- Experimental colitis was induced in BALB/c mice with 4% DSS administration for 7 days. Mice were divided into control, DSS-treated controls, and two groups receiving Co infusion (preventive and curative). Clinical signs, colon length, and inflammatory markers were assessed.
- Both preventive and curative Co treatments reduced weight loss, colonic damage, and pro-inflammatory cytokines.
- This study demonstrates Co’s dual potential as a preventive and curative treatment for colitis.
Abstract: Inflammatory bowel disease (IBD), including ulcerative colitis and Crohn’s disease (CD), is characterized by chronic intestinal inflammation. Current therapeutic strategies, including immunosuppressants and biologics, have limitations such as adverse effects and variable efficacy. Calendula officinalis (Co), a medicinal plant with recognized anti-inflammatory and antioxidant properties, may represent a promising alternative or complementary approach. This study aimed to evaluate the preventive and curative effects of Co infusion in a murine model of ulcerative colitis (UC) induced by dextran sodium sulfate (DSS). Fifty male BALB/c mice were randomly assigned to five groups: control, DSS+water (positive), Co+DSS (preventive), DSS+Co (curative), and DSS (positive). Colitis was induced by the administration of 4% DSS in drinking water for 7 days. Co infusion (2 g/150 mL) was administered orally for 14 days. Clinical parameters, including body weight and the Disease Activity Index (DAI), were recorded. Oxidative stress markers, including myeloperoxidase (MPO), malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), reduced glutathione (GSH), and pro-inflammatory cytokines interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and C-reactive protein (CRP), were assessed. DSS administration induced significant weight loss, inflammation, and colonic oxidative stress. Co infusion significantly attenuated these effects and reduced inflammatory and oxidative markers. The findings suggest that Co may have potential as a preventive and curative agent in IBD management.
Downloads
References
Geier MS, Butler RN, Howarth GS. Inflammatory bowel disease: Current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics. Int J Food Microbiol. 2007;115(1):1-11. http://doi.org/10.1016/j.ijfoodmicro.2006.10.006
Wang Z, Chang Y, Sun H, Li Y, Tang T. Advances in molecular mechanisms of inflammatory bowel disease-associated colorectal cancer (Review). Oncol Lett. 2024;27(6):257. http://doi.org/10.3892/ol.2024.14390
Muro P, Zhang L, Li S, Zhao Z, Jin T, Mao F, Mao Z. The emerging role of oxidative stress in inflammatory bowel disease. Front Endocrinol (Lausanne). 2024;15:1390351. https://doi.org/10.3389/fendo.2024.1390351
Liu D, Saikam V, Skrada KA, Merlin D, Iyer SS. Inflammatory bowel disease biomarkers. Med Res Rev. 2022;42(5):1856-87. http://doi.org/10.1002/med.21893
Baydi Z, Limami Y, Khalki L, Zaid N, Naya A, Mtairag EM, Oudghiri M, Zaid Y. An update of research animal models of inflammatory bowel disease. Sci World J. 2021;2021:7479540. http://doi.org/10.1155/2021/7479540
Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced mouse models of intestinal inflammation. Nat Protoc. 2007;2(3):541-6. http://doi.org/10.1038/nprot.2007.41
Wirtz S, Popp V, Kindermann M, Gerlach K, Weigmann B, Fichtner-Feigl S, Neurath MF. Chemically induced mouse models of acute and chronic intestinal inflammation. Nat Protoc. 2017;12(7):1295-1309. http://doi.org/10.1038/nprot.2017.044
Axelsson LG, Landström E, Goldschmidt TJ, Grönberg A, Bylund-Fellenius AC. Dextran sulfate sodium (DSS)-induced experimental colitis in immunodeficient mice: Effects in CD4(+) cell depleted, athymic and NK-cell depleted SCID mice. Inflamm Res. 1996;45(4):181-91. http://doi.org/10.1007/BF02285159
Kim TW, Seo JN, Suh YH, Park HJ, Kim JH, Kim JY, Oh KI. Involvement of lymphocytes in dextran sulfate sodium-induced experimental colitis. World J Gastroenterol. 2006;12(2):302-5. http://doi.org/10.3748/wjg.v12.i2.302
Huang TC, Tsai SS, Liu LF, Liu YL, Liu HJ, Chuang KP. Effect of Arctium lappa L. in the dextran sulfate sodium colitis mouse model. World J Gastroenterol. 2010;16(33):4193-9. http://doi.org/10.3748/wjg.v16.i33.4193
Theodoraki E, Orfanoudaki E, Petroulaki E, Foteinogiannopoulou K, Koutroubakis IE. Active smoking is associated with the development of adverse events of biological therapy in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2023;35(1):15-20. http://doi.org/10.1097/MEG.0000000000002445
Marsal J, Barreiro-de Acosta M, Blumenstein I, Cappello M, Bazin T, Sebastian S. Management of non-response and loss of response to anti-tumor necrosis factor therapy in inflammatory bowel disease. Front Med (Lausanne). 2022;9:897936. http://doi.org/10.3389/fmed.2022.897936
Higashiyama M, Hokari R. New and emerging treatments for inflammatory bowel disease. Digestion. 2023;104(1):74-81. http://doi.org/10.1159/000527422
Kondamudi PK, Malayandi R, Eaga C, Aggarwal D. Drugs as causative agents and therapeutic agents in inflammatory bowel disease. Acta Pharm Sin B. 2013;3(5):289-96. http://doi.org/10.1016/j.apsb.2013.06.004
Bamba S, Tsujikawa T, Sasaki M, Fujiyama Y, Andoh A. Immunomodulators and immunosuppressants for Japanese patients with ulcerative colitis. ISRN Gastroenterol. 2011;2011:194324. http://doi.org/10.5402/2011/194324
Triantafillidis JK, Triantafyllidi A, Vagianos C, Papalois A. Favorable results from the use of herbal and plant products in inflammatory bowel disease: Evidence from experimental animal studies. Ann Gastroenterol. 2016;29(3):268-81. http://doi.org/10.20524/aog.2016.0059
Triantafyllidi A, Xanthos T, Papalois A, Triantafillidis JK. Herbal and plant therapy in patients with inflammatory bowel disease. Ann Gastroenterol. 2015;28(2):210-220.
Gupta M, Mishra V, Gulati M, Kapoor B, Kaur A, Gupta R, Tambuwala MM. Natural compounds as safe therapeutic options for ulcerative colitis. Inflammopharmacology. 2022;30(2):397-434. http://doi.org/10.1007/s10787-022-00931-1
Arora D, Rani A, Sharma A. A review on phytochemistry and ethnopharmacological aspects of genus Calendula. Pharmacogn Rev. 2013;7(14):179-87. http://doi.org/10.4103/0973-7847.120520
Olennikov DN, Kashchenko NI. Componential profile and amylase inhibiting activity of phenolic compounds from Calendula officinalis L. leaves. Sci World J. 2014;2014:654193. http://doi.org/10.1155/2014/654193
Re TA, Mooney D, Antignac E, Dufour E, Bark I, Srinivasan V, Nohynek G. Application of the threshold of toxicological concern approach for the safety evaluation of Calendula officinalis petals and extracts used in cosmetic and personal care products. Food Chem Toxicol. 2009;47(6):1246-54. http://doi.org/10.1016/j.fct.2009.02.016
Olennikov DN, Kashchenko NI, Chirikova NK, Akobirshoeva A, Zilfikarov IN, Vennos C. Isorhamnetin and quercetin derivatives as anti-acetylcholinesterase principles of marigold (Calendula officinalis) flowers and preparations. Int J Mol Sci. 2017;18(8):1685. http://doi.org/10.3390/ijms18081685
Garrido-Suárez BB, Garrido G, Menéndez AB, Merino N, Valdés O, de la Paz N, Romero A, Delgado L, Fernández MD, Piñeros O, Delgado-Hernández R. Topical Calendula officinalis L. inhibits inflammatory pain through antioxidant, anti-inflammatory, and peripheral opioid mechanisms. J Integr Med. 2022;21:34-46. http://doi.org/10.1016/j.joim.2022.10.002
Basch E, Bent S, Foppa I, Haskmi S, Kroll D, Mele M, Szapary P, Ulbricht C, Vora M, Yong S; Natural Standard Research Collaboration. Marigold (Calendula officinalis L.): An evidence-based systematic review by the Natural Standard Research Collaboration. J Herb Pharmacother. 2006;6(3-4):135-59. http://doi.org/10.1080/j157v06n03_08
Lenoir L, Rossary A, Joubert-Zakeyh J, Vergnaud-Gauduchon J, Farges MC, Fraisse D, Texier O, Lamaison JL, Vasson MP, Felgines C. Lemon verbena infusion consumption attenuates oxidative stress in dextran sulfate sodium-induced colitis in the rat. Dig Dis Sci. 2011;56(12):3534-45. http://doi.org/10.1007/s10620-011-1784-x
Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem. 1968;25(1):192-205. https://doi.org/10.1016/0003-2697(68)90092-4
Zielińska M, Lewandowska U, Podsędek A, Cygankiewicz AI, Jacenik D, Sałaga M, et Kordek R, Krajewska WM, Fichna J. Orally available extract from Brassica oleracea var. capitata rubra attenuates experimental colitis in mouse models of inflammatory bowel diseases. J Funct Foods. 2015;17:587-99.
Pervin M, Hasnat MA, Lim JH, Lee YM, Kim EO, Um BH, Lim BO. Preventive and therapeutic effects of blueberry (Vaccinium corymbosum) extract against DSS-induced ulcerative colitis by regulation of antioxidant and inflammatory mediators. J Nutr Biochem. 2016;28:103-13. http://doi.org/10.1016/j.jnutbio.2015.10.006
Wang F, Fu Y, Cai W, Sinclair AJ, Li D. Anti-inflammatory activity and mechanisms of a lipid extract from hard-shelled mussel (Mytilus coruscus) in mice with dextran sulphate sodium-induced colitis. J Funct Foods. 2016;23:389-99.
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-54. http://doi.org/10.1016/0003-2697(76)90527-3
Bragueto Escher G, Cardoso Borges LDC, Sousa Santos J, Mendanha Cruz T, Boscacci Marques M, Vieira do Carmo MA, Azevedo L, M Furtado M, Sant'Ana AS, Wen M, Zhang L, Granato D. From the field to the pot: Phytochemical and functional analyses of Calendula officinalis L. flower for incorporation in an organic yogurt. Antioxidants. 2019;8(11):559. http://doi.org/10.3390/antiox8110559
Sapkota B, Kunwar P. A Review on Traditional Uses, Phytochemistry and Pharmacological Activities ofCalendula officinalis Linn. Nat Prod Commun. 2024;19(6):1-22. http://doi.org/10.1177/1934578X241259021
Kim JJ, Shajib MS, Manocha MM, Khan WI. Investigating intestinal inflammation in DSS-induced model of IBD. J Vis Exp. 2012;(60):3678. http://doi.org/10.3791/3678
Zhao LP, Wu J, Quan W, Zhou Y, Hong H, Niu GY, Li T, Huang SB, Qiao CM, Zhao WJ, Cui C, Shen YQ. DSS-induced colitis activates the kynurenine pathway in serum and brain by affecting IDO-1 and gut microbiota. Front Immunol. 2023;13:1089200. http://doi.org/10.3389/fimmu.2022.1089200
Banakar SM, Veerapur VP, Thippeswamy BS, Jagadeesh NV, Gavimath CC, Alshehri ZS. Protective effect of Calendula officinalis (L.) flower extract in acetic acid–induced ulcerative colitis in rats. J Herbs Spices Med Plants. 2016;22(3):225-37. http://doi.org/10.1080/10496475.2016.1190952
Preethi KC, Kuttan G, Kuttan R. Anti-inflammatory activity of flower extract of Calendula officinalis Linn. and its possible mechanism of action. Indian J Exp Biol. 2009;47(2):113-20.
Prabhu Venkatesh DSG, Ramani PSR, Ramalingam K. In vitro evaluation of antioxidant and anti-inflammatory potentials of herbal formulation containing marigold flower (Calendula officinalis L.) tea. Cureus. 2023;15(8):e43308. http://doi.org/10.7759/cureus.43308
Alexandre JTM, Sousa LHT, Lisboa MRP, Furlaneto FAC, Val DRD. Anti-inflammatory and antiresorptive effects of Calendula officinalis on inflammatory bone loss in rats. Clin Oral Investig. 2018;22:2175-85. http://doi.org/10.1007/s00784-017-2308-7
Lin W, Chen H, Chen X, Guo C. The roles of neutrophil-derived myeloperoxidase (MPO) in diseases: The new progress. Antioxidants. 2024;13(1):132. http://doi.org/10.3390/antiox13010132
Choudhary S, Keshavarzian A, Yong S, Wade M, Bocckino S, Day BJ, Banan A. Novel antioxidants zolimid and AEOL11201 ameliorate colitis in rats. Dig Dis Sci. 2001;46(10):2222-30. http://doi.org/10.1023/a:1011975218006
Keshavarzian A, Sedghi S, Kanofsky J, List T, Robinson C, Ibrahim C, Winship D. Excessive production of reactive oxygen metabolites by inflamed colon: Analysis by chemiluminescence probe. Gastroenterology. 1992;103(1):177-85. http://doi.org/10.1016/0016-5085(92)91111-G
Sies H, Berndt C, Jones DP. Oxidative stress. Annu Rev Biochem.2017;86:715-48. http://doi.org/10.1146/annurev-biochem-061516-045037
Hashem H, Sadek AM. Antioxidant ameliorating effect of setria (reduced glutathione) on experimentally induced colitis in adult male albino rats. Egypt J Histol. 2021;44(1):188-205.
Averill-Bates DA. The antioxidant glutathione. Vitam Horm. 2023;121:109-41. http://doi.org/10.1016/bs.vh.2022.09.002
Parihar AK, Srivastava S, Patel S, Singh MR, Singh D. Novel catalase loaded nanocores for the treatment of inflammatory bowel diseases. Artif Cells Nanomed Biotechnol. 2017;45(5):981-9. http://doi.org/10.1080/21691401.2016.1198363
Ashique S, Kumar S, Hussain A, Mishra N, Garg A, Gowda BHJ, Farid A, Gupta G, Dua K, Taghizadeh-Hesary F. A narrative review on the role of magnesium in immune regulation, inflammation, infectious diseases, and cancer. J Health Popul Nutr. 2023;42(1):117. http://doi.org/10.1186/s41043-023-00461-8
Preethi KC, Kuttan G, Kuttan R. Antioxidant potential of an extract of Calendula officinalis flowers in vitro and in vivo. Pharm Biol. 2006;44(9):691-7.
Tanideh N, Jamshidzadeh A, Sepehrimanesh M, Hosseinzadeh M, Koohi-Hosseinabadi O, Najibi A, Raam M, Daneshi S, Asadi-Yousefabad SL. Healing acceleration of acetic acid-induced colitis by marigold (Calendula officinalis) in male rats. Saudi J Gastroenterol. 2016;22(1):50-6. http://doi.org/10.4103/1319-3767.173759
Meenatchisundaram S, Parameswar G, Subbraj T, Suganya T, Michael A. Note on pharmacological activities of Calendula officinalis L. Ethnobot Leaflets. 2009;2009(1):5.
Singh MK, Sahu P, Nagori K, Dewangan D, Kumar T, Alexander A, Badwaik H, Tripathi DK. Organoleptic properties in-vitro and in-vivo pharmacological activities of Calendula officinalis Linn: An over review. J Chem Pharm Res. 2011; 3(4):655-63.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Youcef BOUFERKAS, Abir HADDI, Leila AMIER, Kabir Khadija ARGUNGU, Kawthar BELKAALOUL, Samia ADDOU
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.
